Fundraising Fox
Claritas Rx
South San Francisco, US · Founded 2021 · Delaware corporation · 136 employees on LinkedIn · 1 known investors
Find your way into Claritas Rx
Sign up to see every warm intro you have to Claritas Rx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Claritas Rx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Claritas Rx provides AI-powered patient journey analytics and care coordination software for specialty and rare disease pharmaceutical brands, helping identify and remove barriers to patient treatment access and adherence. The platform integrates de-identified pharmacy data with care coordination tools to help healthcare teams optimize medication adherence and reduce treatment abandonment.
Founders & leadership
SK
Stuart KaminSVP, Analytics & InnovationSVP of Analytics & Innovation at Claritas Rx, a software platform providing AI-powered patient journey analytics and care coordination for specialty pharmaceutical brands. Kamin brings expertise in health information technology, health system design, and commercial strategy in the life sciences sector.
MF
Mike FitzgibbonsCEOBefore founding the company in 2011, he spent six years at Genentech, where he served as Group Manager of Pricing Strategy and later as Group Product Manager on the Avastin marketing team. He began his career as a research analyst at Morgan Stanley, a role he held for seven years.
BB
Bhupesh BajajChief Technology OfficerBhupesh Bajaj is a healthcare technology executive with experience leading engineering and product teams at companies acquired by major firms. He has background in SaaS product development, distributed systems, machine learning operations, and cloud infrastructure, with expertise in healthcare compliance including HIPAA and HITECH standards.
MV
Manoshi VasudevanNamed on SEC filing
NK
Nicholas KrokoszynskiNamed on SEC filing
MB
Mauricio BuitragoNamed on SEC filing
Board
BS
Investors · 1
Questa Capitallisted by Questa CapitalSan Francisco · $15M – $40M
How we know: Questa Capital's portfolio page · a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$19.1M disclosed across 4 rounds · 2017–2021
▶$13.6MraisedFeb 2021 · 9 investors · Other TechnologyRule 506(b)
▶$13.6MraisedFeb 2021 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Manoshi VasudevanExecutive Officer
- Nicholas KrokoszynskiExecutive Officer
- Bradley SloanDirector
- Stuart KaminExecutive Officer
- Mauricio BuitragoExecutive Officer
- Michael S FitzgibbonsExecutive Officer, Director
- Offering amount
- $13.6M
- Amount sold
- $13.6M
- Minimum investment
- $25K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$997KraisedJul 2020 · 8 investors · Other TechnologyRule 506(b)
▶$997KraisedJul 2020 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S FitzgibbonsExecutive Officer, Director
- Offering amount
- $997K
- Amount sold
- $997K
- Minimum investment
- $50K
- First sale
- Mar 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$2.9MraisedJul 2020 · 20 investors · Other TechnologyRule 506(b)
▶$2.9MraisedJul 2020 · 20 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S FitzgibbonsExecutive Officer, Director
- Offering amount
- $2.9M
- Amount sold
- $2.9M
- Minimum investment
- $25K
- First sale
- Aug 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedJul 2020 · 8 investors · Other TechnologyRule 506(b)
▶$1.6MraisedJul 2020 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael S FitzgibbonsExecutive Officer, Director
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- Minimum investment
- $25K
- First sale
- Jan 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Claritas Rx went on to found or lead other companies.
Related companies · 3
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Syneos HealthSyneos Health is a fully integrated biopharmaceutical solutions organization that provides clinical, medical affairs, and commercial services to help pharmaceutical companies accelerate market access and patient outcomes.
ConnectiveRxConnectiveRx provides hub services, patient support, and patient affordability programs that help pharmaceutical manufacturers, healthcare providers, and patients access and stay on prescribed therapies. It offers point-of-care awareness and adherence messaging as a single-partner solution for medication access in the pharmaceutical industry.
Companies working in the same space as Claritas Rx.
In the news
Frequently asked questions
- What does Claritas Rx do?
- Claritas Rx provides AI-powered patient journey analytics and care coordination software for specialty and rare disease pharmaceutical brands, helping identify and remove barriers to patient treatment access and adherence. The platform integrates de-identified pharmacy data with care coordination tools to help healthcare teams optimize medication adherence and reduce treatment abandonment.
- Who are Claritas Rx's investors?
- Claritas Rx's investors include Questa Capital.
- How much funding has Claritas Rx raised?
- Claritas Rx has disclosed $19.1M raised across 4 rounds.
- Where is Claritas Rx headquartered?
- Claritas Rx is headquartered in South San Francisco, US.